Silverberg, J., Simpson, E., Ardeleanu, M., Thaçi, D., Barbarot, S., Bagel, J., . . . Akinlade, B. (2019). Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: A pooled analysis of data from two phase III trials. Br J Dermatol.
Citação norma ChicagoSilverberg, J.I., et al. "Dupilumab Provides Important Clinical Benefits to Patients With Atopic Dermatitis Who Do Not Achieve Clear or Almost Clear Skin According to the Investigator's Global Assessment: A Pooled Analysis of Data From Two Phase III Trials." Br J Dermatol 2019.
Deismireacht MLASilverberg, J.I., et al. "Dupilumab Provides Important Clinical Benefits to Patients With Atopic Dermatitis Who Do Not Achieve Clear or Almost Clear Skin According to the Investigator's Global Assessment: A Pooled Analysis of Data From Two Phase III Trials." Br J Dermatol 2019.